| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |